Results 201 to 210 of about 41,988 (241)

The chemistry and pharmacology of synthetic cannabinoid SDB-006 and its regioisomeric fluorinated and methoxylated analogs.

Drug Testing and Analysis, 2018
S. Banister, Alexander Olson, M. Winchester, J. Stuart, Amelia R Edington, R. Kevin, Mitchell Longworth, Marco Herrera, M. Connor, I. McGregor, R. Gerona, M. Kassiou   +11 more
semanticscholar   +1 more source

10.1037/e694232011-006

CrossRef Listing of Deleted DOIs, 2000
openaire   +1 more source

Abstract S5-04: Ten year follow-up of BCIRG-006 comparing doxorubicin plus cyclophosphamide followed by docetaxel (AC→T) with doxorubicin plus cyclophosphamide followed by docetaxel and trastuzumab (AC→TH) with docetaxel, carboplatin and trastuzumab (TCH) in HER2+ early breast cancer

, 2016
D. Slamon, W. Eiermann, N. Robert, J. Giermek, M. Martín, M. Jasiówka, J. Mackey, A. Chan, M.-C. Liu, T. Pintér, V. Valero, C. Falkson, T. Fornander, T. Shiftan, S. Bensfia, S. Hitier, N. Xu, V. Bee-Munteanu, P. Drevot, M. Press, J. Crown   +20 more
semanticscholar   +1 more source

QAS-006

2012
openaire   +1 more source

10.1037/e661462007-006

CrossRef Listing of Deleted DOIs, 2000
openaire   +1 more source

In vitro metabolism of new synthetic cannabinoid SDB-006 in human hepatocytes by high-resolution mass spectrometry

Forensic Toxicology, 2017
X. Diao, J. Carlier, K. Scheidweiler, M. Huestis   +3 more
semanticscholar   +1 more source

Case 006

2005
openaire   +1 more source

10.1037/e592452007-006

CrossRef Listing of Deleted DOIs, 2000
openaire   +1 more source

Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival analysis of KEYNOTE-006.

, 2016
J. Schachter, A. Ribas, G. Long, A. Arance, J. Grob, L. Mortier, A. Daud, M. Carlino, C. McNeil, M. Lotem, J. Larkin, P. Lorigan, B. Neyns, C. Blank, T. Petrella, O. Hamid, Honghong Zhou, S. Ebbinghaus, N. Ibrahim, C. Robert   +19 more
semanticscholar   +1 more source

10.1037/e481752008-006

CrossRef Listing of Deleted DOIs, 2000
openaire   +1 more source